Numerous challenges face any emerging company developing a biopharmaceutical. How you anticipate hurdles, plan for contingencies and communicate with stakeholders will play a big part in determining your success.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
22 September 2011
In the version of this article initially published online, the author wrote, “This suggested a market potential in the billions of dollars…” The sentence should have read, “This suggested a larger market potential…” The error has been corrected for the print, PDF and HTML versions of this article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fernandes, P. Headwinds into opportunity. Nat Biotechnol 29, 864–866 (2011). https://doi.org/10.1038/nbt1011-864
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1011-864
